Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of DLBS-32 in Type 2 Diabetes
NCT01005069Phase 2Completed
- Sponsor
- Dexa Medica
- Start
- Oct 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DLBS-32 in type 2 diabetes mellitus (T2DM), sponsored by Dexa Medica. Started Oct 2009; status: completed.
02
Drugs
DLBS-32
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01005069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005069.